Literature DB >> 9568102

Hyaluronic acid binding capacity of malignant glioma cells.

M M Knüpfer1, H Poppenborg, M Hotfilder, M Domula, J E Wolff.   

Abstract

The mechanisms underlying the rapid invasive growth of malignant gliomas are poorly understood. Adhesion to extracellular hyaluronic acid (HA) has been implicated in the invasive properties of tumor cells. We investigated the HA binding capacity of human (T98G, A172, U87MG, 86HG39, 85HG66) and rat (C6, 9L) glioma cell lines by means of HA coated, bovine serum albumin (BSA)-blocked (HA/BSA) and only BSA-blocked culture plates. Results were compared with adhesion to native wells (100% adhesion). Adhesion to HA/BSA was high for T98G (84.4%), medium for 86HG39 (36%), 9L (33.1%), A172 (35.5%) and low for 85HG66 (21.3%) and U87MG (26.8%). Adhesion to only BSA-coated wells was significantly lower in all these cell lines, suggesting a specific HA-adhesion. Only C6 showed similar adhesion to HA/BSA and BSA alone, therefore, C6 failed to bind HA specifically. These results suggest that adhesion to extracellular HA might be involved in the invasion of some gliomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568102

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  CD44 expression and hyaluronic acid binding of malignant glioma cells.

Authors:  M M Knüpfer; H Poppenborg; M Hotfilder; K Kühnel; J E Wolff; M Domula
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine.

Authors:  Michał Seweryn Karbownik; Tadeusz Pietras; Janusz Szemraj; Edward Kowalczyk; Jerzy Zygmunt Nowak
Journal:  Contemp Oncol (Pozn)       Date:  2014-09-23

Review 3.  The scrambled story between hyaluronan and glioblastoma.

Authors:  Matías Arturo Pibuel; Daniela Poodts; Mariángeles Díaz; Silvia Elvira Hajos; Silvina Laura Lompardía
Journal:  J Biol Chem       Date:  2021-03-17       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.